Country: South Africa
Language: English
Source: South African Health Products Regulatory Authority (SAHPRA)
Abbott Laboratories S.A. (Pty) Ltd
See ingredients
POWDER
EACH 10,0 g POWDER CONTAINS LACTULOSE 10,0 g
Registered
1996-03-05
Page 1 of 8 PATIENT INFORMATION LEAFLET SCHEDULING STATUS: DUPHALAC DRY, 10 G POWDER FOR ORAL SOLUTION Contains sugar: 10 g lactose _READ ALL OF THIS LEAFLET CAREFULLY BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU _ DUPHALAC DRY is available without a doctor’s prescription, for you to treat a mild illness. Nevertheless, you still need to use DUPHALAC DRY carefully to get the best results from it. • Keep this leaflet. You may need to read it again. • Do not share DUPHALAC DRY with any other person. • Ask your health care provider or pharmacist if you need more information or advice. • You must see a doctor if your symptoms worsen or do not improve after 3 days._ _ WHAT IS IN THIS LEAFLET 1. What DUPHALAC DRY is and what it is used for 2. What you need to know before you use DUPHALAC DRY 3. How to use DUPHALAC DRY 4. Possible side effects 5. How to store DUPHALAC DRY 6. Contents of the pack and other information 1. WHAT DUPHALAC DRY IS AND WHAT IT IS USED FOR DUPHALAC DRY oral solution sachets contain a laxative called lactulose. It makes the stool softer and easier to pass, by drawing water into the bowel. It is not absorbed into your body. DUPHALAC DRY is used to treat the symptoms of constipation (infrequent bowel movements, hard and dry stools). DUPHALAC DRY is indicated in adults and in children and S0 Page 2 of 8 adolescents aged 1 to 18 years. Lactulose is used to treat portal systemic encephalopathy (a liver disease causing confusion, tremor, decreased level of consciousness). You must talk to a doctor if you do not feel better or if you feel worse after 3 days. 2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE DUPHALAC DRY DO NOT TAKE DUPHALAC DRY: • if are hypersensitive (allergic) to lactulose; • if you suffer from galactosaemia (a severe genetic disorder where you cannot digest galactose); • if you have a blockage in your bowel (apart from normal constipation). WARNINGS AND PRECAUTIONS Special care should be taken with DUPHALAC DRY. Talk to your doctor or pharmacist before taking DUPHALAC DRY Read the complete document
Page 1 of 9 PROFESSIONAL INFORMATION SCHEDULING STATUS 1. NAME OF THE MEDICINE DUPHALAC DRY 10 g of Duphalac Dry contains 10 g lactulose Crystalline powder 2. QUALITATIVE AND QUANTITATIVE COMPOSITION 10 g of DUPHALAC DRY contains 10 g lactulose (4-0-ᵦ-D-galactopyranosyl-D-fructofuranose) (a maximum of 0,25 g galactose and 0,2 g lactulose). For the full list of excipients, see section 6 .1. DUPHALAC DRY contains residues from the route of production with known effect, see section 4.4. 3. PHARMACEUTICAL FORM A white to slightly yellow coloured crystalline powder. 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS A) CONSTIPATION Particularly when associated with laxative habituation or for those patients in whom constipation presents a special problem, e.g. children, obstetric and post-surgical patients. B) PORTAL SYSTEMIC ENCEPHALOPATHY Hepatic coma or precoma stages where hyperammonaemia is present. S0 Page 2 of 9 4.2 POSOLOGY AND METHOD OF ADMINISTRATION POSOLOGY A) CONSTIPATION The dosage for constipation can be varied according to the individual response, but the following serves as a guide. Starting dose (3 days) gram per day Maintenance dose gram per day Adults 10-30 g 10-20 g Children 7-14 years 10 g 10 g Children 1-6 years 5-10 g 5-10 g If there is no response within 48 hours the dosage can be increased and if diarrhoea occurs dosage should be decreased. Since DUPHALAC DRY exerts its effect when it reaches the colon it may take 1-2 days before normal defaecation occurs. B) PORTAL SYSTEMIC ENCEPHALOPATHY Starting dose 20-35 g three times a day. Maintenance dose has to be adjusted to the individual response. DUPHALAC DRY can be taken with breakfast cereals, or drinks such as tea, coffee, fruit juice or milk. Page 3 of 9 4.3 CONTRAINDICATIONS Hypersensitivity to lactulose (see section 6.1) Galactosaemia including patients on a galactose-free diet. Patients with intestinal obstruction. 4.4 SPECIAL WARNINGS AND PRECAUTIONS FOR USE In case of insufficient therapeutic effect after several days consultation of Read the complete document